Clinical Trial

Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study

Study acronym: SAFE
Recruiting
View on ClinicalTrials.gov →
Summary
Electrical/pharmacological cardioversion improves structural remodeling of left atrium. We hypothesized that radiofrequency ablation surgery for atrial fibrillation has a higher success rate and a lower recurrence rate of atrial fibrillation in patients with improved atrial stroma. This study is a multicenter, prospective, observational study conducted in China to evaluate whether sacubitril/valsartan can reduce atrial fibrillation recurrence rates, improve cardiac structure and function, and analyze the factors influencing the maintenance rate of sinus rhythm after atrial fibrillation ablation.
Trial Details
NCT Number NCT07129564
Lead Sponsor Yuehui Yin
Conditions Atrial Fibrillation
Enrollment 480 participants
Start Date 2023-04-27
Primary Completion 2024-11-25 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-19